Comparison With GLP-1 Receptor Agonists Studies have compared sitagliptin with GLP-1 receptor agonists in drug nave subjects with type 2 diabetes [exenatide, (110)] or as add on to other therapy for exenatide (111), semaglutide (112), albiglutide (113), and dulaglutide (114)
DOI: 10.1200/OP-26-00485 The study was supported by the American College of Radiology Center for Research and Innovation, the Pennsylvania Breast Cancer Coalition, and the Abramson Cancer Center
In this study, we investigated for the first time the effect of TXR treatment on KA-induced excitotoxicity and its relationship with Gal- 3 expression
Collagen supports skin structure and glutathione protects that structure from oxidative stress
doi:10.1016/bs.vh.2022.01.011 Kumrungsee T, Peipei Z, Yanaka N, Suda T, Kato N